Literature DB >> 33888907

Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.

Janie F Shelton1, Anjali J Shastri1, Chelsea Ye1, Catherine H Weldon1, Teresa Filshtein-Sonmez1, Daniella Coker1, Antony Symons1, Jorge Esparza-Gordillo2, Stella Aslibekyan1, Adam Auton3.   

Abstract

COVID-19 presents with a wide range of severity, from asymptomatic in some individuals to fatal in others. Based on a study of 1,051,032 23andMe research participants, we report genetic and nongenetic associations with testing positive for SARS-CoV-2, respiratory symptoms and hospitalization. Using trans-ancestry genome-wide association studies, we identified a strong association between blood type and COVID-19 diagnosis, as well as a gene-rich locus on chromosome 3p21.31 that is more strongly associated with outcome severity. Hospitalization risk factors include advancing age, male sex, obesity, lower socioeconomic status, non-European ancestry and preexisting cardiometabolic conditions. While non-European ancestry was a significant risk factor for hospitalization after adjusting for sociodemographics and preexisting health conditions, we did not find evidence that these two primary genetic associations explain risk differences between populations for severe COVID-19 outcomes.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33888907     DOI: 10.1038/s41588-021-00854-7

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  52 in total

1.  How the mixed-race mestizo myth warped science in Latin America.

Authors:  Emiliano Rodríguez Mega
Journal:  Nature       Date:  2021-12       Impact factor: 49.962

Review 2.  The genetic and evolutionary determinants of COVID-19 susceptibility.

Authors:  Gaspard Kerner; Lluis Quintana-Murci
Journal:  Eur J Hum Genet       Date:  2022-06-28       Impact factor: 5.351

Review 3.  Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.

Authors:  Ranjan Ramasamy
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

Review 4.  The human genetic epidemiology of COVID-19.

Authors:  Mari E K Niemi; Mark J Daly; Andrea Ganna
Journal:  Nat Rev Genet       Date:  2022-05-02       Impact factor: 59.581

5.  Association Between the LZTFL1 rs11385942 Polymorphism and COVID-19 Severity in Colombian Population.

Authors:  Mariana Angulo-Aguado; David Corredor-Orlandelli; Juan Camilo Carrillo-Martínez; Mónica Gonzalez-Cornejo; Eliana Pineda-Mateus; Carolina Rojas; Paula Triana-Fonseca; Nora Constanza Contreras Bravo; Adrien Morel; Katherine Parra Abaunza; Carlos M Restrepo; Dora Janeth Fonseca-Mendoza; Oscar Ortega-Recalde
Journal:  Front Med (Lausanne)       Date:  2022-06-20

6.  Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort.

Authors:  Michael Inouye; Guillaume Méric; Youwen Qin; Aki S Havulinna; Yang Liu; Pekka Jousilahti; Scott C Ritchie; Alex Tokolyi; Jon G Sanders; Liisa Valsta; Marta Brożyńska; Qiyun Zhu; Anupriya Tripathi; Yoshiki Vázquez-Baeza; Rohit Loomba; Susan Cheng; Mohit Jain; Teemu Niiranen; Leo Lahti; Rob Knight; Veikko Salomaa
Journal:  Nat Genet       Date:  2022-02-03       Impact factor: 38.330

7.  MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.

Authors:  Shay Ben Shachar; Noam Barda; Sigal Manor; Sapir Israeli; Noa Dagan; Shai Carmi; Ran Balicer; Bracha Zisser; Yoram Louzoun
Journal:  J Clin Immunol       Date:  2021-05-29       Impact factor: 8.317

8.  Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals.

Authors:  Jack A Kosmicki; Julie E Horowitz; Nilanjana Banerjee; Rouel Lanche; Anthony Marcketta; Evan Maxwell; Xiaodong Bai; Dylan Sun; Joshua D Backman; Deepika Sharma; Fabricio S P Kury; Hyun M Kang; Colm O'Dushlaine; Ashish Yadav; Adam J Mansfield; Alexander H Li; Kyoko Watanabe; Lauren Gurski; Shane E McCarthy; Adam E Locke; Shareef Khalid; Sean O'Keeffe; Joelle Mbatchou; Olympe Chazara; Yunfeng Huang; Erika Kvikstad; Amanda O'Neill; Paul Nioi; Meg M Parker; Slavé Petrovski; Heiko Runz; Joseph D Szustakowski; Quanli Wang; Emily Wong; Aldo Cordova-Palomera; Erin N Smith; Sandor Szalma; Xiuwen Zheng; Sahar Esmaeeli; Justin W Davis; Yi-Pin Lai; Xing Chen; Anne E Justice; Joseph B Leader; Tooraj Mirshahi; David J Carey; Anurag Verma; Giorgio Sirugo; Marylyn D Ritchie; Daniel J Rader; Gundula Povysil; David B Goldstein; Krzysztof Kiryluk; Erola Pairo-Castineira; Konrad Rawlik; Dorota Pasko; Susan Walker; Alison Meynert; Athanasios Kousathanas; Loukas Moutsianas; Albert Tenesa; Mark Caulfield; Richard Scott; James F Wilson; J Kenneth Baillie; Guillaume Butler-Laporte; Tomoko Nakanishi; Mark Lathrop; J Brent Richards; Marcus Jones; Suganthi Balasubramanian; William Salerno; Alan R Shuldiner; Jonathan Marchini; John D Overton; Lukas Habegger; Michael N Cantor; Jeffrey G Reid; Aris Baras; Goncalo R Abecasis; Manuel A R Ferreira
Journal:  Am J Hum Genet       Date:  2021-06-03       Impact factor: 11.043

Review 9.  Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.

Authors:  Joaquín Dopazo; Douglas Maya-Miles; Federico García; Nicola Lorusso; Miguel Ángel Calleja; María Jesús Pareja; José López-Miranda; Jesús Rodríguez-Baño; Javier Padillo; Isaac Túnez; Manuel Romero-Gómez
Journal:  J Pers Med       Date:  2021-05-26

10.  Mapping the human genetic architecture of COVID-19.

Authors: 
Journal:  Nature       Date:  2021-07-08       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.